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During the last decades, the involvement of redox reac-
tions in each aspect of cellular physiology has emerged,
rapidly steadied, and is currently assuming extensive con-
notations. From a mere pathological condition leading to
widespread biomolecules damage and cell degeneration,
(over)production of reactive oxygen and nitrogen species
(ROS and RNS, resp.) is now also deemed to be among
the early upstream events of signal transduction pathways
governing cellular response. It is now well established that
the thiol moiety of reactive cysteines is the main molecular
switch selected by the evolution to transduce a redox signal.
Even at physiological pH, the sulfhydryl group of these
residues is present under thiolate form and primed to be
modified by ROS and RNS in a reversible manner. S-
nitrosylation, S-hydroxylation, and S-glutathionylation are,
indeed, all oxidations that meet the conditions of specificity
and reversibility required for a chemical modification (sig-
nal) being transduced in a biological event (response).
In this special issue, the double-faced role of nitroxidative
stress (deleterious, or signal mediator) has been carefully
considered, mostly in regards to the implications that it could
have in neurodegeneration. The paper by R. P. Guttmann
and T. J. Powell underlines this aspect elucidating, in the
first part, the biochemical basis of the high susceptibility
of brain towards redox stress and providing, in the second
one, a very clear overview of the possible sources, mech-
anisms, and targets of oxidative stress, namely cysteine-
containing enzymes, which can be implicated in the onset of
neurodegenerative diseases. Although it is still unclear
whether oxidative stress is the primary initiating event or
a secondary effect related to other pathological conditions,
its role in neurodegenerative diseases is confirmed by the
evidence that the brain is particularly prone to ROS and
RNS production and susceptible to their harmful effects.
Its high metabolic rate and content of oxidizable molecules,
(e.g., neurotransmitters), as well as the high concentration
of redox-active metals (e.g., iron and copper) and the
limiting levels of antioxidants, mainly glutathione (GSH),
are features concurring to exacerbate oxidative challenges
in the central nervous system (CNS). These aspects have
been fully covered in a series of papers included in this
special issue. In particular, R. B. Mounsey and P. Teismann
dissect out in depth the contribution of iron accumulation
in Parkinson’s disease (PD) and debate the promising on-
going pharmacological approaches aimed at reversing this
phenomenon, including the use of both synthetic and natural
iron chelators. C. Consales et al. deal with the emerging
lines of evidence linking electromagnetic fields (EMF) and
neurodegenerative diseases onset. They discuss about the still
not reconciled results reporting both neuroprotective and
pro-oxidant role of EMF and critically assess methodological
limitations that could affect pathophysiological relevance of
any alteration found in EMF-exposed biological systems. The
paper by W. Li et al. complements the information on the
role of environmental factors in exacerbating pro-oxidant
conditions in neurodegeneration, by providing a very inter-
esting overview of the role of GSH in brain homeostasis and
protection. Remarkably, besides the role of GSH in driving
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cell signaling and redox state maintenance, the authors shed
new light on its involvement in the control of neurovascular
function. GSH-mediated protection against endothelial cell
injury and promotion of postdamage cell proliferation in
endothelial repair are discussed on the basis of the very
recent lines of evidence reporting the involvement of GSH-
dependent redox modification (e.g., S-glutathionylation) in
cerebral microvascular biology and pathobiology, as well as
in oxidative stress-associated neurovascular disorders, such
as stroke and diabetes. The paper by L. Rossi et al. concludes
this part of the special issue revisiting the current opinion
regarding the role of oxidative stress in motor neuron
diseases (MNDs). Interestingly the authors provide convinc-
ing evidence that increased oxidative stress, mitochondrial
damage, and altered gene expression (due to epigenetic
defects and RNA dysmetabolism) are common features of
different MDNs that could underlie MDNs pathogenesis.
Amongst the environmental factors contributing to
neurodegenerative diseases, chemicals and drugs affecting
the mitochondrial electron transport chain (e.g., paraquat
and rotenone) are frequently reported to induce apoptotic
cell death. However, endogenous molecules have also been
demonstrated to be detrimental if produced in excess, such
as glutamate or certain cytokines. Recently, the macrophage
migration inhibitory factor (MIF), a macrophage-produced
cytokine, has been reported to be involved in disease
pathogeneses. In this special issue, N. E. Savaskan provide
an overview of our current knowledge about MIF action,
especially regarding its potential role in brain disease and
redox regulation in apoptosis. Neuronal apoptosis is an
important mechanism contributing to the selective loss of
cell populations in specific regions of the CNS. It can
take place via the mitochondrial pathway, the main step
of which is the release of the mitochondrial respiration
mediator cytochrome c within the cytosol. On this topic, L.
Berghella and E. Ferraro provide an original research paper
dissecting out in depth the sequence of events of neuronal
apoptosis. They provide evidence that cytosolic cytochrome
c has no role in chromatin condensation and that it is not
a primary cause of mitochondrial respiration impairment,
which occurs long before its release. These results are in
agreement with the current knowledge suggesting that the
effects of apoptotic-associated dysfunction onmitochondrial
respiration are not mere epiphenomena, but are rather
crucial for proper execution of the apoptotic program. In
particular, themassive production of ROS and the generation
of pro-oxidant state favoring the activation of downstream
apoptotic factors are gaining increasing importance. Indeed,
mitochondria represent an important endogenous source of
ROS that are physiologically generated at the mitochondrial
electron transport chain. The sustained and long-lasting pro-
duction of ROS is the principal cause of nitroxidative damage
to biomolecules. It can produce DNA damage and, in the
long term, it can give rise to established somatic mutations.
These effects can contribute to neoplastic transformation
and are detrimental to neuronal viability. In this special issue,
D. De Zio et al. deeply address this topic, providing a detailed
overview regarding the occurrence of oxidative DNA damage
in neurons and how it is specifically counteracted by the
activity of DNA repair systems. The authors discuss how the
unbalance between these processes results in neurodevelop-
ment disorders and neurodegenerative diseases and focus on
the role of the nuclear factor Ku70/80 as pivotal mediator
of neuronal viability. Likewise, S. Gonfloni et al. discuss the
role of the c-Abl tyrosine kinase, as its increased activation
has been reported in several neurological disorders. They
provide a paper in which they propose that c-Abl signaling
contributes to modulate molecular events at the interface
between oxidative stress, metabolism, and DNA damage,
suggesting possible therapeutic strategies targeting c-Abl for
the treatment of neurodegenerative diseases.
Besides being an important site for ROS production, the
mitochondrial electron transport chain generates the proton
motive force that is used for ATP synthesis by the F0/F1
ATP synthase. The mitochondrial transmembrane potential
(ΔΨm) is a measure of the proton electrochemical gradient
generated across the mitochondrial inner membrane and
represents a good indicator of the energy status of the mito-
chondrion. Under certain pathophysiological conditions,
such as hypoxia-ischemia, ΔΨm can be transiently preserved
at the expense of ATP. This is brought about by the reverse
reaction of F0/F1 ATPase, which can hydrolyze glycolytically
generated ATP to pump protons into the intermembrane
space, thusmaintaining theΔΨm. In this special issue, D. Fac-
cenda andM. Campanella provide an up-to-date overview of
mitochondrial energetics and the molecular characterization
of F0/F1 ATPase, highlighting its function and the regulatory
events that trigger either the ATP-synthesizing or the ATP-
hydrolyzing activities. The authors focus on the role of
the inhibitory factor 1 (IF1), a polypeptide that responds
to mitochondrial intermembrane space acidification by
inhibiting the ATP-hydrolyzing activity of the F0/F1 ATPase;
this occurs by stabilizing its dimerization status via a
molecular link between two F1 domains. This molecular
rearrangement remodels the mitochondrial cristae structure
and, consequently, regulates organelle morphology, thus
involving IF1 in neurodegeneration and cancer. Given that
mitochondrial healthy state strongly impacts on the genera-
tion of intracellular nitroxidative stress conditions, chronic
alterations of mitochondrial homeostasis are among the
events concurring to the onset of several pathological states,
namely cancer and neurodegenerative diseases. Nevertheless,
it should be also reminded that mitochondria have evolved
specific molecular quality control mechanisms to counteract
the damaging effects of nitroxidative stress. In this special
issue E. Desideri and L. M. Martins provide an overview of
the current knowledge of mitochondrial quality control and
discuss the pivotal role that PTEN-induced putative kinase
1 (PINK1) and the protease high-temperature-regulated A2
(HTRA2) might play in this context. In particular, they
report evidence and speculate about the possibility that
defects in their activity might contribute to PD onset.
From a metabolic perspective, neurons and cancer cells
exhibit sharp differences. Neurons strictly depend on effi-
cient OXPHOS for ATP production; here, mitochondrial
respiration does not depend directly on glucose availability
and is rather fueled by pyruvate derived from glia-provided
lactate in a Cori’s cycle-like manner. Glucose taken up
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by neurons is instead mainly redirected to the pentose
phosphate pathway, allowing the generation of NADPH to
sustain the indispensable sulfhydryl reductive pathways and
antioxidant response. By contrast, tumor cells synthesize ATP
almost entirely by means of glycolysis even in normoxic
conditions, when oxygen availability is not restricted (the
“Warburg effect”). This condition represents a major change
of the entire metabolic reprogramming typical of tumors
and allows cancer cells to grow even under low oxygen
tension, when tumor vascularization is still incomplete, and
therefore, local vessels fail to supply adequate amount of
oxygen. Upregulation of the glycolytic pathway is therefore
a selective advantage to sustain the ATP demand required for
tumor proliferation under hypoxic conditions. M. Fernandes
de Oliveira et al. comprehensively review the mitochondrial
biochemical pathways underlying bioenergetics, ATP pro-
duction, and ROS generation in cancer. The authors also
discuss the connection betweenmitochondrial dynamics and
function, and how this is related to apoptotic cell response.
In detail, they give emphasis to the role of ROS and RNS
in the activation of redox-sensitive transcription factors
and protein kinases in tumor cells, and how they can be
manipulated to selectively kill them. Along this line, M. Soga
et al. discuss recent data underlying the tight liaison between
redox state alteration and mitogen-activated protein kinases
(MAPKs) activation, namely the apoptosis signal-regulating
kinase 1 (ASK1). Being the Ichijo’s laboratory among the
pioneers to have characterized the role of thioredoxin (Trx)
as the regulatory partner of ASK1, in this paper, the authors
revisit the main steps of this regulation and provide the new
lines of evidence arguing for the involvement of ASK1 in
several pathological states.
As previously mentioned, metabolic reprogramming of
tumor cells synergizes with nitroxidative stress to maintain
and develop tumor aggressiveness. T. Fiaschi and P. Chiarugi
deepen this concept in their paper and extend it to the
entire tumor microenvironment that, together with stromal
cells, enhances pro-oxidant conditions and concurs to the
establishment of a more aggressive and chemoinsensitive
neoplastic phenotype. To corroborate the intrinsic connec-
tion between metabolism and tumorigenesis, S. Cardaci and
M. R. Ciriolo discuss the causative role of mutations in
three enzymes belonging to the tricarboxylic acid (TCA)
cycle, succinate dehydrogenase (SDH), fumarate hydratase
(FH), and isocitrate dehydrogenase (IDH). Together with K.
Smolkova´ and P. Jezˇek, who reviewed in detail the oncogenic
potential of the mitochondrial isoform of IDH, these authors
highlight how point mutations of these enzymes generate
an hypoxia-like phenotype, affect cellular redox state, and
interfere with DNA methylation dynamics, thereby revealing
the main tumor-promoting effects of TCA cycle alterations.
To complete this section, N. Berndt et al. develop a kinetic
model aimed at predicting and quantifying mitochondrial
OXPHOS efficiency and ROS production induced by the
reduced activity of α-ketoglutarate dehydrogenase (KGDH).
This condition occurs in several neurodegenerative diseases,
such as PD and Alzheimer’s disease (AD), and the results
shown in this paper give strength to the hypothesis that
decreased KGDH activity plays a pivotal role in the ener-
getic failure of neuronal cells during neurodevelopment
and neurodegeneration. KGDH is a multienzymatic com-
plex responsible for the conversion of α-ketoglutarate into
succinyl-CoA, a critical step in the TCA cycle. The TCA
cycle is a central hub in metabolism; its functions are not
restricted to energy conservation and involve afferent as
well as efferent anabolic pathways. α-ketoglutarate is an
important intermediate for afferent processes because it is
the catabolic product of several amino acids and is also
generated by deamination or transamination of glutamate.
α-ketoglutarate is therefore essential for energy production
from amino acid substrates. On the other hand, efferent
pathways generate new amino acids from the sugars entering
the TCA cycle, which are indispensable for cancer cells to
synthesize new proteins and produce biomass. The levels
of amino acids in the extracellular milieu are sensed by
the multimolecular mTOR complex 1 (mTORC1) and
transduced viawell-known signaling axes that lead to normal
cell growth or autophagy. Here, mTOR serves as master
metabolic switch; whenmTOR is active, it promotes anabolic
metabolism repressing autophagy, and when it is inactive
(e.g., during nutrient starvation) or inhibited (e.g., by
rapamycin), cells switch to a catabolic mode. In the latter
case, autophagy is activated to recycle proteins, whereas
organelles and protein synthesis are repressed. Although
autophagy is a homeostatic process for normal cells, it is also
exploited by cancer cells to grow and survive under restrictive
conditions such as nutrient deprivation, which occurs in the
core of solid tumors. The paper by V. Banerji and S. B. Gibson
deals with the emerging relationship between metabolic
changes of tumor cells and autophagy, and how it contributes
to increase cancer progression and chemoresistance. It has
been reported that this feature depends on the increased
expression of NF-E2-related factor-2 (Nrf2), a transcription
factor that induces detoxifying and antioxidant systems, such
as molecular chaperones and GSH-regenerating enzymes.
Although Nrf2 activity is necessary for cell protection against
nitroxidative stress, in several tumor histotypes, its basal
activation is overinduced. Several somatic mutations have
been demonstrated to destroy the interaction between Nrf2
and its physiological inhibitor, Kelch-like ECH-associated
protein 1 (Keap1), thereby promoting the persistent activa-
tion of the Nrf2-mediated response and tumorigenesis. The
paper by R. Brigelius-Flohe´ et al. discusses the dichotomous
role of Nrf2 and highlights how Nrf2 activation results in
the expression of several selenium-containing antioxidant
enzymes (e.g., Trx reductase and GSH peroxidase) that con-
tribute to enhance the deleterious aspects of Nrf2 in tumor
progression.
Although mitochondria are the main intracellular pro-
ducers of nitroxidative stress, it should be considered that
they are also the primary targets of oxidative damage, a
concept that has inspired the mitochondrial theory of aging.
This aspect has been also taken into account in this special
issue and deepened in virtue of its possible involvement in
cancer and neurodegeneration. In this context, the paper
of P. B. L. Pun and M. P. Murphy provides a very inter-
esting overview on the novel role of intracellular glycation
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reactions as oxidative modifications specifically affecting the
mitochondrial compartment, and how these can contribute
to disease pathology. P. Sarti et al. discuss about the double
(cytoprotective or detrimental) role of nitric oxide (NO)
within mitochondria and, in particular, they describe the
inhibitory effect of modifications of cytochrome c oxidase at
different sites. The authors report a very detailed biochemical
dissection of the different NO-mediated modifications of the
mitochondrial complex IV and elucidate the environmental
conditions in which they can occur, alongside the patho-
physiological effects they can produce. This aspect is also
addressed by R. M. Santos et al., who debate about the in
vivo implications of NO signaling, focusing on the molecular
mechanisms affecting bioenergetics and neurological dis-
orders. Among these mechanisms, S-nitrosylation regulates
protein function and modulates cellular homeostasis. In
this field, Lipton’s laboratory has greatly contributed to our
better understanding of the implication of S-nitrosylation in
cellular physiology. Thus, in this special issue, M. W. Akhtar
provide a straightforward overview of proteins found to
undergo S-nitrosylation that are directly involved in PD and
AD pathogenesis. This paper is complemented by that of G.
Di Giacomo, who specifically covered the partially neglected
role of denitrosylation processes in NO-mediated signaling
pathways, mainly those catalyzed by S-nitrosoglutathione
reductase (GSNOR). They report the most recent lines of
evidence arguing for this enzyme being implicated in patho-
physiology and discuss how it can impact on mitochondrial
function, dynamics, and selective removal by autophagy
(the so-called mitophagy). Mitochondria, indeed, are highly
dynamic organelles; they can fuse to form an interconnected
network or undergo fission to form fragmented units that
can in turn fuse again. Alternatively, fragmented mitochon-
dria can be engulfed in autophagosome membranes for
removal. These processes take place in response to different
stimuli impinging on the fusion/fission machinery, mediated
by a series of mitochondria-shaping proteins, such as the
large GTPase family members mitofusins (Mfns) and optic
atrophy 1 protein (Opa1), which underlie fusion events, and
dynamin-related protein 1 (Drp1) required for mitochon-
drial fragmentation. The paper by M. Corrado et al. provides
a detailed description of the molecular processes underlying
mitochondrial dynamics. They also define how alterations in
its correct occurrence can affect cellular viability and lead to
pathological states, for example, cancer, neurodegeneration,
and neuroinflammatory diseases.
In addition to the continuous change of size, shape and
removal by mitophagy, mitochondria are also neosynthe-
sized. This process—mitochondrial biogenesis—is funda-
mental to ensure the generation of new mitochondria to
maintain a constant mass of the organelle within the cell.
It has been recently proposed that mitochondrial biogenesis
is subjected to redox regulation as well, and this leads
to hypothesize a general regulatory mechanism in which
the appropriate magnitude of mitochondrial biogenesis is
finely tuned by the very same early mediators of mitophagy,
namely ROS and RNS. This aspect is also addressed in this
special issue by the paper of E. D. Yoboue and A. Devin,
who dissect out in depth the redox responsive transcription
factors underlying mitochondrial biogenesis, such as the
peroxisome proliferator-activated receptor gamma coactiva-
tor 1-α (PGC1-α). D. Lettieri Barbato et al. deepen this
concept and extend the “redox model” of mitochondrial
biogenesis towards a general responsiveness to further condi-
tions affecting redox state, including caloric restriction. The
authors suggest that oxidative stress and caloric restriction
share the same signaling pathways that converge on PGC1-
α to promote the expression of mitochondrial genes and
speculate how these factors can be manipulated by means of
nutritional intervention to prevent neurodegeneration.
That mitochondria are not only the “power station”
of the cells is now a well-established notion, which is
progressively enriched by novel insights of previously unsus-
pected functions and possible interplays with other cellu-
lar compartments. Overall, these elements strengthen the
concept that mitochondria contribute in several aspects to
the progression of pathologies. One of the most recent
structural connections to be functionally characterized is
the one occurring between mitochondria and endoplasmic
reticulum (ER). It takes place through specific ER structures,
the so-called mitochondrial-associated membrane (MAM),
whose finding drove research to unravel the molecular
mechanisms underlying the cellular processes bridging the
two organelles. In particular, in the last years, it is becoming
clear howmitochondria and ER participate to lipid-mediated
signaling, calcium homeostasis, and apoptosis. In regards to
this, the research paper by S. Perez-Alvarez et al. identifies
in the perturbation of calcium homeostasis, the mechanism
of methadone-induced neuronal cell death, which underlies
its negative impact on human cognition. In particular, the
authors provide evidence that methadone induces delayed
calcium deregulation (DCD) by compromising the mito-
chondrial network and its ability to uptake calcium in
a respiratory-dependent way. These results strengthen the
functional association between mitochondria and ER in cell
death pathways but also provide the proof of principle that
additional processes (e.g., metabolism, respiration) could be
regulated in concert with the two compartments. Along this
line, MAM has been indicated to contain chaperons (e.g.,
Grp78) and proteins directly involved in oxidative protein
folding, such as Ero1-α and protein disulfide isomerase
(PDI). This is significant in the light of the fact that
defects in protein folding induce the unfolded protein
response (UPR), which can ultimately lead to the intrinsic
(mitochondrial-mediated) pathway of apoptosis. It has been
also demonstrated that, via MAM, Ero1-α competes with the
mitochondrial electron tranport chain for oxygen availability
and represents the main hydrogen peroxide producers within
ER. Besides being crucial for protein folding, the high levels
of pro-oxidant molecules within the ER are also required
to reversibly regulate the function of proteins residing in
this compartment. Indeed, redox regulation of ER-contained
proteins and enzymes has been exhaustively reported. In this
special issue, we have addressed this aspect and attempted
to enlighten the involvement of the tight relationship among
mitochondria, oxidative stress, and ER in disease onset. To
this aim, we provide a series of papers aimed at deepening
the current knowledge and reporting novel findings that
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shed new light on this topic. Results reported by Y. Xiong
et al. show that treatment of breast cancer cells with the
NO donor PABA/NO induces S-glutathionylation of PDI,
impairs its chaperone-like activity, and induces apoptosis via
the activation of UPR. In particular, the authors provide
evidence that the activation of cell death is associated with
inability of the S-glutathionylated PDI to bind to the estrogen
receptor α (ERα) with consequent inhibition of the expres-
sion of genes involved in cell proliferation. Nevertheless, if
the impairment of PDI activity and the aberrant activation
of UPR could be exploited for cancer cell killing, it has
been copiously reported to be detrimental for neuronal
viability. Indeed, the accumulation of unfolded protein and
excessive UPR are among the causes triggering neuronal
cell death in a large number of neurodegenerative diseases.
In this context, E. Ferreiro et al. elucidate the association
between pathological changes found in AD brain (e.g.,
protein inclusion) and mitochondrial dysfunction, and how
oxidative stress resulting from this condition is intimately
linked to ER-derived ROS production and UPR. The paper
by F. Di Sano and M. Piacentini adds new insights to this
aspect by focusing on the role of reticulons family, and of
RTN-1C in particular, in different neuron pathologies. RTN-
1C is localized on ER membranes and regulates ER structure
and function; in their paper, the authors provide strong lines
of evidence that this protein might be a promising target in
the treatment of different pathologies.
In conclusion, the field of redox biology has grown
beyond all expectations and now interests virtually every bio-
logical process. Perturbation in redox balance and signaling
has indisputable relevance in the pathobiology of cancer and
neurodegenerative diseases, and restoration of homeostasis
constitutes an appealing therapeutic strategy. This special
issue recapitulates the state of the art of redox biology in
relation to these disorders and highlights the most critical
priorities to achieve better understanding of pathogenesis
and develop successful therapies. We are therefore confident
that this collection will be highly informative for those in the
field as well as for the broad scientific community.
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